PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:22 AM ET

Sponsor Check › Person

GC
No photo found yet (own website and image search run after this page is viewed)

Gerald Chan

Named as an officer, director or promoter on SEC Form D filings · MA · Aug 3, 2009 → Jul 15, 2025

11deals (issuers)
$761.4Mreported sold
194investors
28Form D filings
2009–2025years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Gerald Chan is listed as a director on 28 SEC Form D filings by 11 issuers between Aug 2009 and Jul 2025. Largest by amount reported sold: Cognito Therapeutics Group, Inc. (Cambridge, MA — other health care — 2025; $196.3M reported sold to 23 investors), Morningside China TMT Fund II, L.P. (Causeway Bay, Hong Kong (as filed: K3) — pooled investment fund — 2011; $130.9M reported sold to 13 investors), Cognito Therapeutics Ltd. (Cambridge, MA — other health care — 2022–2024; $108.8M reported sold to 13 investors), Atea Pharmaceuticals, Inc. (Boston, MA — biotechnology — 2016–2018; $107.5M reported sold to 59 investors), Apnimed, Inc. (Cambridge, MA — pharmaceuticals — 2018–2021; $79.7M reported sold to 14 investors) and 6 more (all listed below).

What this means That is a lot of deals — 11 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $761.4M sold in total.

Listed alongside Barry Wohl (6 shared filings), Dennis Molnar (6 shared filings), Joseph C. Avellone (6 shared filings), Lawrence G. Miller (6 shared filings), Alec Machiels (5 shared filings) and 59 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gerald. Each name links to their own page.

The issuers belong to 4 sponsor groups: Cognito Therapeutics (2 issuers, $206.5M reported sold, 2022–2025), Critical (3 issuers, $6.85M reported sold, 2009–2015), Apellis (3 issuers, $24.9M reported sold, 2010–2025) and Morningside China Tmt (8 issuers, $1.16B reported sold, 2011–2015).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 28 public filings for Gerald Chan and found 14 differences, 1 worth asking the sponsor about: 6 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Gerald Chan has not run yet — it is joining a line of 31,833 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Gerald Chan..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Gerald F. Chan and Jennifer A. Chan closed
United States Bankruptcy Court, N.D. Illinois · No. 10-13800 · Filed Mar 30, 2010 · Closed Mar 30, 2012
Role of Gerald F. Chan and Jennifer A. Chan: Debtor · Outcome: Case closed 2012-03-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 5 federal dockets); 8 people with this name in Form D filings; court in IL (not a filing state)
Gerald B. Chan closed
United States Bankruptcy Court, E.D. California · No. 09-21808 · Filed Feb 3, 2009 · Closed May 15, 2009
Role of Gerald B. Chan: Debtor · Outcome: Case closed 2009-05-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 5 federal dockets); 8 people with this name in Form D filings; court in CA (not a filing state)
Gerald F. Chan and Jennifer A. Chan closed
United States Bankruptcy Court, N.D. Illinois · No. 07-22769 · Filed Dec 4, 2007 · Closed Jan 19, 2010
Role of Gerald F. Chan and Jennifer A. Chan: Debtor · Outcome: Case closed 2010-01-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 5 federal dockets); 8 people with this name in Form D filings; court in IL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

14 differences found between the filings for Gerald Chan — 1 worth asking about (compared 28 filings on Oct 24, 2026)

Note · Aug 3, 2009

22% of the money raised went to insiders — CRITICAL BIOLOGICS CORP

The Aug 3, 2009 Form D reports $500,000 sold and $109,140 of the proceeds used for payments to officers, directors or promoters. Issuer's note: "The amount disclosed was used to pay salaries of officers and directors in the ordinary course of business and not paid as a form of remuneration for the offering.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Aug 3, 2009 ↗CRITICAL BIOLOGICS CORP — PartnerFacts page ↗
Sources
Note · Aug 3, 2009 – Jul 11, 2014

Gerald Chan appears on 2 deals that stopped filing before reaching their target

SYNCHRONEURON INC. (last filing Jul 11, 2014; $3,500,054 sold of $19,999,992); CRITICAL BIOLOGICS CORP (last filing Aug 3, 2009; $500,000 sold of $1,600,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

SYNCHRONEURON INC. — PartnerFacts page ↗CRITICAL BIOLOGICS CORP — PartnerFacts page ↗
Sources
Worth asking · Apr 21, 2011 – Jul 15, 2025

6 Form Ds were filed more than 15 days after the first sale

Form D filed 84 days after the first sale — NEUTROLIS INC. · Form D filed 25 days after the first sale — NEUTROLIS INC. · Form D filed 39 days after the first sale — NEUTROLIS INC. · Form D filed 17 days after the first sale — Atea Pharmaceuticals, Inc. · Form D filed 46 days after the first sale — Apellis Pharmaceuticals, Inc. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Dec 3, 2021 ↗NEUTROLIS INC. — PartnerFacts page ↗Form D · Jul 15, 2025 ↗Form D · Apr 8, 2025 ↗
Sources
Note · Jul 24, 2009 – Jul 15, 2025

11 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — NEUTROLIS INC. (latest filing Jul 15, 2025) · No amendment in the last 12 months on an offering that may still be open — NEUTROLIS INC. (latest filing Apr 8, 2025) · No amendment in the last 12 months on an offering that may still be open — Cognito Therapeutics Ltd. (latest filing Jul 2, 2024) · No amendment in the last 12 months on an offering that may still be open — Cognito Therapeutics Ltd. (latest filing Nov 15, 2023) · No amendment in the last 12 months on an offering that may still be open — NEUTROLIS INC. (latest filing Dec 3, 2021) · and 6 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jul 15, 2025 ↗NEUTROLIS INC. — PartnerFacts page ↗Form D · Apr 8, 2025 ↗Form D · Jul 2, 2024 ↗
Sources
Note · Dec 17, 2014 – Jun 9, 2015

Offering amount lowered between filings — Apellis Pharmaceuticals, Inc.

The Dec 17, 2014 filing says $21,500,000 offered; the Jun 9, 2015 Form D/A says $17,732,150.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Dec 17, 2014 ↗Form D/A (later) · Jun 9, 2015 ↗Apellis Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 6, 2018 – Mar 25, 2021

Industry group changed between filings — Apnimed, Inc.

"Other Health Care" (Jul 6, 2018 to Apr 7, 2020); then "Pharmaceuticals" (Mar 25, 2021).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 6, 2018 ↗Form D · Mar 25, 2021 ↗Apnimed, Inc. — PartnerFacts page ↗
Sources
Note · Dec 17, 2014 – Jan 6, 2016

Industry group changed between filings — Apellis Pharmaceuticals, Inc.

"Biotechnology" (Dec 17, 2014 to Jun 9, 2015); then "Pharmaceuticals" (Jan 6, 2016 to Aug 17, 2017).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Dec 17, 2014 ↗Form D · Jan 6, 2016 ↗Apellis Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Feb 16, 2012 – Jul 11, 2014

Industry group changed between filings — SYNCHRONEURON INC.

"Pharmaceuticals" (Feb 16, 2012); then "Other Health Care" (Jul 11, 2014).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Feb 16, 2012 ↗Form D · Jul 11, 2014 ↗SYNCHRONEURON INC. — PartnerFacts page ↗
Sources
Note · Dec 17, 2014 – Jan 6, 2016

Reported revenue range changed between filings — Apellis Pharmaceuticals, Inc.

"$1 - $1,000,000" (Dec 17, 2014); then "Decline to Disclose" (Jan 6, 2016).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Dec 17, 2014 ↗Form D · Jan 6, 2016 ↗Apellis Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · May 10, 2012 – Oct 19, 2026

Same name, different state: "Gerald Chan" (TX) is a separate record

This page covers filings where the address state is MA. A separate record, "Gerald Chan" with address state TX, is listed on 3 filings — most recently by Elementium Materials, Inc. (Oct 19, 2026). Both records have filings in the same period (May 10, 2012 to Jul 15, 2025).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Gerald Chan (TX) — PartnerFacts page ↗Form D · Oct 19, 2026 ↗Elementium Materials, Inc. — PartnerFacts page ↗Gerald Chan (MA) — this page ↗
Sources
Note · Dec 15, 2020

Same name, different state: "Gerald Chan" (X0) is a separate record

This page covers filings where the address state is MA. A separate record, "Gerald Chan" with address state X0, is listed on 1 filing — most recently by LumiraDx Ltd (Dec 15, 2020). Both records have filings in the same period (Dec 15, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Gerald Chan (X0) — PartnerFacts page ↗Form D · Dec 15, 2020 ↗LumiraDx Ltd — PartnerFacts page ↗Gerald Chan (MA) — this page ↗
Sources
Note · Aug 5, 2013 – Apr 11, 2019

Same name, different state: "Gerald Chan" (O9) is a separate record

This page covers filings where the address state is MA. A separate record, "Gerald Chan" with address state O9, is listed on 3 filings — most recently by Stavvy, Inc. (Apr 11, 2019). Both records have filings in the same period (Aug 5, 2013 to Apr 11, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Gerald Chan (O9) — PartnerFacts page ↗Form D · Apr 11, 2019 ↗Stavvy, Inc. — PartnerFacts page ↗Gerald Chan (MA) — this page ↗
Sources
Note · Feb 20, 2014 – Sep 4, 2015

Same name, different state: "Gerald Chan" (K3) is a separate record

This page covers filings where the address state is MA. A separate record, "Gerald Chan" with address state K3, is listed on 8 filings — most recently by MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P. (Sep 4, 2015). Both records have filings in the same period (Feb 20, 2014 to Sep 4, 2015).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Gerald Chan (K3) — PartnerFacts page ↗Form D · Sep 4, 2015 ↗MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P. — PartnerFacts page ↗Gerald Chan (MA) — this page ↗
Sources
Note · Jun 13, 2014 – Jan 5, 2015

Same name, different state: "Gerald David Chan" (CA) is a separate record

This page covers filings where the address state is MA. A separate record, "Gerald David Chan" with address state CA, is listed on 2 filings — most recently by ADURO BIOTECH, INC. (Jan 5, 2015). Both records have filings in the same period (Jun 13, 2014 to Jan 5, 2015).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Gerald David Chan (CA) — PartnerFacts page ↗Form D · Jan 5, 2015 ↗ADURO BIOTECH, INC. — PartnerFacts page ↗Gerald Chan (MA) — this page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 23 offerings report sales commissions totalling $286,499; 0 report finder's fees; 2 report proceeds to related persons totalling $289,140. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 15, 2025 D
NEUTROLIS INC.
File 021-551762
$0$0$0None listed on this filingEDGAR ↗
Apr 8, 2025 D
NEUTROLIS INC.
File 021-543136
$0$0$0None listed on this filingEDGAR ↗
Apr 1, 2025 D
Cognito Therapeutics Group, Inc.
File 021-542681
$0$0$0None listed on this filingEDGAR ↗
Jul 2, 2024 D
Cognito Therapeutics Ltd.
File 021-517621
$0$0$0None listed on this filingEDGAR ↗
Nov 15, 2023 D/A
Cognito Therapeutics Ltd.
File 021-450926
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2021 D
NEUTROLIS INC.
File 021-423574
$0$0$0None listed on this filingEDGAR ↗
Jul 6, 2021 D
Linus Health, Inc.
File 021-405294
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2021 D
Apnimed, Inc.
File 021-393539
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2020 D
Linus Health, Inc.
File 021-377028
$0$0$0None listed on this filingEDGAR ↗
Apr 13, 2020 D
Stealth BioTherapeutics Corp
File 021-364841
$0$0$0None listed on this filingEDGAR ↗
Apr 7, 2020 D
Apnimed, Inc.
File 021-364430
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2019 D
Stealth BioTherapeutics Corp
File 021-351049
$0$0$0None listed on this filingEDGAR ↗
Aug 7, 2019 D/A
Apnimed, Inc.
File 021-316175
$0$0$0None listed on this filingEDGAR ↗
Jul 16, 2018 D
Atea Pharmaceuticals, Inc.
File 021-316941
$119,499$0$0CIM Securities, LLC BrokerCheck CRD 120852 ↗EDGAR ↗
Aug 17, 2017 D
Apellis Pharmaceuticals, Inc.
File 021-293019
$0$0$0None listed on this filingEDGAR ↗
Sep 13, 2016 D
Atea Pharmaceuticals, Inc.
File 021-270551
$167,000 (est.)$0$0Sinh Ly no CRD number reported
via CIM Securities (CRD 120852 ↗)
EDGAR ↗
Feb 8, 2016 D
Apellis Pharmaceuticals, Inc.
File 021-256958
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2016 D
Apellis Pharmaceuticals, Inc.
File 021-254589
$0$0$0None listed on this filingEDGAR ↗
Jun 9, 2015 D/A
Apellis Pharmaceuticals, Inc.
File 021-230281
$0$0$0None listed on this filingEDGAR ↗
Jul 11, 2014 D
SYNCHRONEURON INC.
File 021-220786
$0$0$0None listed on this filingEDGAR ↗
Feb 16, 2012 D
SYNCHRONEURON INC.
File 021-173596
$0$0$180,000None listed on this filingEDGAR ↗
Jun 2, 2011 D
Morningside China TMT Fund II, L.P.
File 021-160705
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2009 D
CRITICAL BIOLOGICS CORP
File 021-99265
$0$0$109,140
The amount disclosed was used to pay salaries of officers and directors in the ordinary course of business and not paid as a form of remuneration for the offering.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 11

Every issuer that named Gerald Chan on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

N
Biotechnology

NEUTROLIS INC.

Cambridge, MA · Dec 3, 2021 → Jul 15, 2025 · 3 filings
  • Jul 15, 2025 · D · $3,500,000 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 8, 2025 · D · $964,955 sold of $1,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2021 · D · $23,136,190 sold of $40,636,190 · 28 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $23.1M from 28 investors (100% of the $10M target) as of the latest filing. Gerald is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Other Health Care · group: Cognito Therapeutics

Cognito Therapeutics Group, Inc.

Cambridge, MA · Apr 1, 2025
  • Apr 1, 2025 · D · $196,250,015 sold of $196,250,015 · 23 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $196.3M from 23 investors (100% of the $196.3M target) as of the latest filing. Gerald is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Other Health Care · group: Cognito Therapeutics

Cognito Therapeutics Ltd.

Cambridge, MA · Jul 1, 2022 → Jul 2, 2024 · 3 filings
  • Jul 2, 2024 · D · $10,249,997 sold of $60,032,626 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 15, 2023 · D/A · $108,765,300 sold of $126,175,917 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2022 · D · $53,332,027 sold of $126,175,917 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $108.8M from 13 investors (100% of the $60M target) as of the latest filing. Gerald is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LH
Other

Linus Health, Inc.

Waltham, MA · Oct 2, 2020 → Jul 6, 2021 · 2 filings
  • Jul 6, 2021 · D · $43,939,990 sold of $54,899,983 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2020 · D · $9,875,578 sold of $9,875,578 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $43.9M from 5 investors (80% of the $54.9M target) as of the latest filing. Gerald is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Pharmaceuticals

Apnimed, Inc.

Cambridge, MA · Jul 6, 2018 → Mar 25, 2021 · 6 filings
  • Mar 25, 2021 · D · $24,999,982 sold of $24,999,982 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2020 · D · $15,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 7, 2019 · D/A · $25,575,714 sold of $25,575,714 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 10, 2019 · D/A · $19,575,714 sold of $25,575,714 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 9, 2018 · D/A · $9,575,714 sold of $25,575,714 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 6, 2018 · D · $5,075,713 sold of $25,575,714 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $79.7M from 14 investors (100% of the $25M target) as of the latest filing. Gerald is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SB
Biotechnology

Stealth BioTherapeutics Corp

Grand Cayman, Cayman Islands (as filed: E9) · Oct 15, 2019 → Apr 13, 2020 · 2 filings
  • Apr 13, 2020 · D · $20,000,001 sold of $20,000,001 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2019 · D · $14,999,999 sold of $14,999,999 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20M from 1 investor (100% of the $20M target) as of the latest filing. Gerald is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Biotechnology

Atea Pharmaceuticals, Inc.

Boston, MA · Sep 13, 2016 → Jul 16, 2018 · 2 filings
  • Jul 16, 2018 · D · $27,599,934 sold of $27,599,934 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 13, 2016 · D · $20,829,775 sold of $20,829,775 · 29 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $107.5M from 59 investors (100% of the $27.6M target) as of the latest filing. Gerald is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals · group: Apellis

Apellis Pharmaceuticals, Inc.

Crestwood, KY · Dec 17, 2014 → Aug 17, 2017 · 5 filings
  • Aug 17, 2017 · D · $20,033,322 sold of $60,099,974 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 8, 2016 · D · $47,135,951 sold of $47,135,951 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 6, 2016 · D · $32,135,952 sold of $32,135,952 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 9, 2015 · D/A · $17,732,150 sold of $17,732,150 · 1 investors · min. $10,000 · role: Director EDGAR ↗
  • Dec 17, 2014 · D · $6,000,000 sold of $21,500,000 · 1 investors · min. $10,000 · role: Director EDGAR ↗

Raised $47.1M from 25 investors (78% of the $60.1M target) as of the latest filing. Gerald is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other Health Care

SYNCHRONEURON INC.

Waltham, MA · Feb 16, 2012 → Jul 11, 2014 · 2 filings
  • Jul 11, 2014 · D · $3,500,054 sold of $19,999,992 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 16, 2012 · D · $1,999,992 sold of $5,999,975 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.5M from 1 investor (18% of the $20M target) as of the latest filing. Gerald is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MC
Pooled Investment Fund · group: Morningside China Tmt

Morningside China TMT Fund II, L.P.

Causeway Bay, Hong Kong (as filed: K3) · Jun 2, 2011
  • Jun 2, 2011 · D · $130,900,000 sold of $250,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $130.9M from 13 investors (52% of the $250M target) as of the latest filing. Gerald is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CB
Biotechnology · group: Critical

CRITICAL BIOLOGICS CORP

Cambridge, MA · Aug 3, 2009
  • Aug 3, 2009 · D · $500,000 sold of $1,600,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $500K from 12 investors (31% of the $1.6M target) as of the latest filing. Gerald is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (7)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Gerald Chan — Hong Kong (as filed: K3), 7 issuers, Feb 20, 2014 → Sep 4, 2015 · no shared issuer
  • Gerald Chan — TX, 3 issuers, May 10, 2012 → Oct 19, 2026 · no shared issuer
  • Gerald Chan — Monaco (as filed: O9), 2 issuers, Aug 5, 2013 → Apr 11, 2019 · shares 1 issuer with this record
  • Gerald Chan — CA, 2 issuers, Dec 12, 2016 → Aug 3, 2017 · no shared issuer
  • Gerald David Chan — CA, 1 issuer, Jun 13, 2014 → Jan 5, 2015 · no shared issuer
  • Gerald Chan — United Kingdom (as filed: X0), 1 issuer, Dec 15, 2020 → Dec 15, 2020 · no shared issuer
  • Gerald Lokchung Chan — MA, 1 issuer, May 2, 2011 → May 2, 2011 · shares 1 issuer with this record

People around Gerald 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

MC
Management entity

Morningside China TMT GP II, L.P.

Promoter · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

TG
Management entity

TMT General Partner Ltd.

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Molnar

Director, Executive Officer · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

BW
No photo found yet (own website and image search run after this page is viewed)
Person

Barry Wohl

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence G. Miller

Executive Officer, Director · 6 shared filings (1 issuer) · also on 6 other issuers

Lawrence G. Miller is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph C. Avellone

Director · 6 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Sinclair Dunlop

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephanie O'Brien

Director · 5 shared filings (1 issuer) · also on 7 other issuers

Stephanie O'Brien is on 8 issuers in total — a repeat sponsor. Their page lists every one.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Cedric Francois

Executive Officer, Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gerald Chan. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Pascal Deschatelets

Executive Officer · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Gerald Chan. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alec Machiels

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gerald Chan. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Ron Farquhar

Director · 5 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bihua Chen

Director · 4 shared filings (2 issuers) · also on 28 other issuers

Bihua Chen is on 30 issuers in total — a repeat sponsor. Their page lists every one.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Bruso

Director · 4 shared filings (2 issuers) · also on 4 other issuers

Stephen Bruso is on 6 issuers in total — a repeat sponsor. Their page lists every one.

HL
No photo found yet (own website and image search run after this page is viewed)
Person

Helen Liang

Director · 4 shared filings (2 issuers)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Kuntz

Director · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Watson

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Geffken

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

NP
No photo found yet (own website and image search run after this page is viewed)
Person

Nicole Perry

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

AA
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Aiudi

Director, Executive Officer, Promoter · 3 shared filings (1 issuer) · also on 5 other issuers

Anthony Aiudi is on 6 issuers in total — a repeat sponsor. Their page lists every one.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Toby Fox

Executive Officer, Director, Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Abdul Hakkim Rahamathullah

Executive Officer, Director, Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

BV
No photo found yet (own website and image search run after this page is viewed)
Person

Brent Vaughan

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

IC
No photo found yet (own website and image search run after this page is viewed)
Person

Isaac Cheng

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Isaac Cheng is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Adelman

Director · 2 shared filings (1 issuer) · also on 12 other issuers

Robert Adelman is on 13 issuers in total — a repeat sponsor. Their page lists every one.

BF
No photo found yet (own website and image search run after this page is viewed)
Person

Barry S. Fogel

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

MARC R. COTE

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

FG
No photo found yet (own website and image search run after this page is viewed)
Person

Federico Grossi

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Bruno Lucidi

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

EZ
No photo found yet (own website and image search run after this page is viewed)
Person

Evgeny Zatsev

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Polsky

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

EO
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Owens

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

LH
No photo found yet (own website and image search run after this page is viewed)
Person

Lu Huang

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gerald Chan. Their page shows their other deals.

IM
No photo found yet (own website and image search run after this page is viewed)
Person

Irene McCarthy

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Francis Chen

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Lou Lange

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

JY
No photo found yet (own website and image search run after this page is viewed)
Person

Justin Yap

Executive Officer, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alvaro Pascual-Leone

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Laura Brege

Director · 2 shared filings (2 issuers)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

John Sundy

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gerald Chan. Their page shows their other deals.

The team behind the deals

CT
Sponsor group

Cognito Therapeutics

2 issuers · 4 filings · $206.5M reported sold · 2022–2025

One team, 2 deal companies. Gerald Chan is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Gerald Chan.

C
Sponsor group

Critical

3 issuers · 3 filings · $6.85M reported sold · 2009–2015

One team, 3 deal companies. Gerald Chan is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Gerald Chan.

A
Sponsor group

Apellis

3 issuers · 20 filings · $24.9M reported sold · 2010–2025

One team, 3 deal companies. Gerald Chan is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Gerald Chan.

MC
Sponsor group

Morningside China Tmt

8 issuers · 10 filings · $1.16B reported sold · 2011–2015

One team, 8 deal companies. Gerald Chan is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Gerald Chan.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Gerald Chan by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Gerald Chan is listed on: none on file. No website or social profile named in Cognito Therapeutics Group, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #73,688 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗Kentucky state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗Kentucky Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Gerald Chan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →